Dopamine D1 and D4 receptors (D1 (for Dopamine receptor D1), D4 (for Dopamine receptor D4))

Dopamine receptor D1 and dopamine receptor D4 are two important members of the dopamine receptor family, which belong to the G protein-coupled receptor (GPCR) superfamily. Both D1 and D4 are primarily expressed in the brain and are involved in signal transduction by binding the neurotransmitter dopamine. D1 is associated with the D1-like receptor family, and couples to Gs/olf proteins to activate adenylyl cyclase and stimulate cAMP production, mediating motor and cognitive functions[4][5][1]. D4 is part of the D2-like family and couples to Gi/o proteins, inhibiting adenylyl cyclase and contributing to regulation of attention, impulse control, and emotional processes[1][6]. Dysregulation of D1 and D4 signaling is implicated in multiple neuropsychiatric and neurological disorders; thus, they are regarded as important therapeutic targets for drug development[2][6][4][1]. Selective agonists, antagonists, and modulators of these receptors have clinical and research significance, though optimal drugs are still being developed due to challenges in selectivity, efficacy, and safety[2][4][6].

Other names

D1 receptorDRD1D4 receptorDRD4

Agonists: activate receptor-mediated G protein signaling (D1: Gs/olf; D4: Gi/o), leading to cAMP pathway modulation Antagonists: block receptor activation, preventing downstream signaling Allosteric modulators: modify receptor response through non-orthosteric sites Heteromeric modulation: formation of receptor complexes (e.g., D2-D4), altering signaling